Artificial Pancreas Devices Market Forecast 2024–2035
Market Overview The Artificial Pancreas Devices System Market is emerging as one of the most transformative segments in diabetes care, driven by the rising global burden of diabetes and the increasing demand for automated, patient-friendly glucose management solutions. Valued at approximately $2.5 billion in 2024, the market is projected to reach nearly $9.8 billion by 2034, expanding at a strong CAGR of around 14.6%. Artificial pancreas systems integrate continuous glucose monitors (CGMs), insulin pumps, and advanced control algorithms to mimic the glucose-regulating function of a healthy pancreas. These systems are designed to reduce the burden of manual insulin management, improve glycemic control, and enhance overall quality of life for patients. With healthcare systems worldwide prioritizing digital health and automation, these devices are steadily shifting from niche innovations to mainstream diabetes management tools. Click to Request a Sample of this Report for Additiona...